A price action above 340 supports a bullish trend direction. Bullish confirmation for a break above 354.00. The target price is set at 397.00. The stop-loss price is set at 322 (its 50% Fibonacci retracement level). Breaking above its 200-day might trigger further upside potential. Remains a risky trade.
A price action above 448 supports a bullish trend direction. The stock is testing its 200-day simple moving average. A change in sentiment towards bullish might occur. Further bullish confirmation for a break above 478. Profit target is at 498. Stop-loss is at 443. Type of a broadening top pattern is busy unfolding. The upper range is highlighted by the 200-week...
A price action below 460 supports a bearish trend direction. The stock is testing its 200-day simple moving average. A confirmed cross below this level will change the sentiment to a full-blown bearish sentiment. Increase short exposure for a break below 450. The target price is set at 420. Stop-loss at 490. Negate the bearish stance for a break above 460. The...
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory...
He must break the enemy. Let's look for closure where I specified with X. The targets were determined according to Fibonacci.
The PEAD projected a Bullish outlook for $BIO after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 90%.
$BIO had the bears winning for the last year, but looks like Bulls are starting to pile up and a tag of war is on the verge. NYSE:BIO
The PEAD projected a Neutral outlook for $BIO after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 33.33%.
We are finishing 1 to 5 Elliot wave theory and expecting price to bounce around 450$ zone. Entry: 450 (institutional candle zone) Invalidation 422 (Below buy zone) Target: 644 (top of daily accumulation zone)
Up Trend going on, Good Technical and Fundamental so Target 1070, Duration 1 to 5 months...
Although this pattern looks bullish. It might not take call options on it because the beta is low. It might not even be worth my while. Reminder, my trichotomy is comprised of dividend yield < 2%, beta >1 and mkt cap > 15B.
-D1 ascending triangle broken by the top -RSI over 50% -D1 big neutrality zone of RSI -Big bullish trend -Last resistance has been broken Wait that RSI or Price goes back to the green zone
Strong fundamentals. Risks are related to the nature of the business However, as the pandemic folds and healthcare sector accelerates, companies like $BIO, $QDEL, $LH are the ones behind the scenes.
Caught by my algo scanner with good PL ratio. Today big green candle on nice volume showing good strength of continuation of upward movement. Its look similar to my NYSE:TMO idea, reference below.
BIO BUY CALL 600 jun18 6000$ 218days cmp: 599 pro: 1.Health care sector is a hot sector during covid 2. weekly demand and bouncing in daily as confirmation 3.Aggreessive stock 4.Stock making constantly HH HL in weekly demand
Hello dear investors, This article is about rare situation, when net margin is bigger then operating margin. Such situation need to be analyzed well to understanding potential of the company. This happen from external or internal reasons: 1. When company can’t pay taxes and/or have tax benefits. Company will not pay taxes untill she will get net profit...
nice upward trend, seems like we are in wave 4 for A,B,C pattern, nice entry point at where the green box is.